Health
Gene therapy to the inner retina prevents blindness in mouse model of CLN3 Batten disease – News-Medical.Net
Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease.
Reviewed by Emily Henderson, B.Sc.Aug 10 2020
Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease. Adeno-associated viral (AAV)-mediated expression of the human CLN3 gene led to significant survival of bipolar cells and pre-served retinal function, as reported in the peer-reviewed journal Human Gene Therapy.
Batten disease is a group of fatal, inherited lysosomal storage disorders that predominantly affect children. The m…
-
Noosa News17 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General17 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News9 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General6 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania